Global Endoscopic Vessel Harvesting System market By System Type: (EVH Systems, Endoscopes, Accessories) By Usability: (Disposable, Reusable) By Vessel-Type: (Saphenous Vein, Radial Artery) By Application: (Coronary Artery Disease, Peripheral Artery Disease), by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Endoscopic Vessel Harvesting System market Overview:

The global Endoscopic Vessel Harvesting System market is projected to reach a valuation of USD 4741.77 Mn by 2032 at a CAGR of 6.1%, from USD 2330.00 Mn in 2021.

The Endoscopic Vessel Harvesting (EVH) System is a technique that can be used in synchroneity with coronary artery bypass surgery. This method involves small incisions and minimally invasive instruments to operate and remove healthy blood vessels with minimum tissue damage. Smaller incisions result in decreased infection rates and pain, resulting in a faster recovery rate.

The EVH system has lesser wound complications in comparison to other techniques of vessel harvesting, and even has lesser scarring and lesser pain as well. The radial artery and saphenous vein are removed from the leg for use as a bypass graft in coronary surgery with the help of endoscopic vessel harvesting systems. The endoscopic approach of the system provides improved patient comfort and post-operative recovery after the surgical procedure has been carried out.

Detailed Segmentation:

The endoscopic vessel harvesting systems market is segmented on the basis of – system type, usability, vessel type, application, and region:

By System Type:

• EVH Systems
• Endoscopes
• Accessories

By Usability:

• Disposable
• Reusable

By Vessel-Type:

• Saphenous Vein
• Radial Artery

By Application:

• Coronary Artery Disease
• Peripheral Artery Disease

By Region:

• North America
• Europe
• APAC
• South America
• MEA

Market Dynamics:

Booming geriatric populations, the increasing prevalence of cardiovascular diseases, increasing technological advancements likely to add novel opportunities, and the growing preference for minimally invasive harvesting, are factors attributed to boosting revenue growth of the global endoscopic vessel harvesting system’s market over the forecast period. Increasing investments in R&D activities and new product development with frequent partnerships being undertaken as an attempt to diversify product portfolios are expected to be key parameters to maintain a competitive edge among industry players.

Key Players:

• Getinge AB
• LivaNova PLC
• Terumo Corporation
• Saphena Medical Inc.
• KARL STORZ
• Med Europe S.r.l.
• Other Key Players

Key Developments:

In August 2019, Terumo Corporation invested US$ 50 Mn in two US-based venture capital funds, Strategic Healthcare Investment Partners (S.H.I.P) and Catalyst Health Ventures (CHV). This investment is expected to enrich internal R&D with new technology, and expanded strategies, and would also complement business development and acquisition as well.

In June 2018, Saphena Medical Inc. was awarded a group purchasing agreement as a Breakthrough Technology with Premier, a national healthcare improvement company. Saphena Medical’s Venapax Endoscopic Vessel Harvesting System is the first unitary EVH system on the market that allows for the saphenous vein or radial artery to be harvested for a coronary artery bypass graft procedure in a single comprehensive system. This agreement gives premier members access to pre-negotiated pricing for the Venapax system.

In February 2018, LivaNova plc entered into an agreement to acquire TandemLife, a privately-held company focused on advanced cardiopulmonary temporary support solutions (“TandemLife”). The Pittsburgh-based company offers four product systems, all built around a common pump and controller. These systems, which include ExtraCorporeal Life Support (“ECLS”) and Percutaneous Mechanical Circulatory Support (“PMCS”), are complementary to LivaNova’s strong offerings in cardiac surgery.
In May 2021, PENTAX Medical (a division of HOYA Group) and Jiangsu Vedkang Medical Science and Technology Co. Ltd. (Vedkang) announced the establishment of a joint venture – PENTAX Medical Therapeutics (Jiangsu) Co. Ltd. to develop single-use therapeutics products in the field of flexible medical endoscopy.

For the Endoscopic Vessel Harvesting System Market research study, the following years have been considered to estimate the market size: